Celgene

In 1986 was created Celgene, which is appeared as Corporate Investor. The venture was found in North America in United States. The main office of represented Corporate Investor is situated in the Summit.

The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Celgene, startups are often financed by Kleiner Perkins, ARCH Venture Partners, OrbiMed. The meaningful sponsors for the fund in investment in the same round are The Column Group, OUP (Osage University Partners), Kleiner Perkins. In the next rounds fund is usually obtained by The Column Group, Kleiner Perkins, GV.

This Celgene works on 2 percentage points more the average amount of lead investments comparing to the other organizations. The fund is constantly included in 2-6 deals per year. The average startup value when the investment from Celgene is 500 millions - 1 billion dollars. The increased amount of exits for fund were in 2018. The common things for fund are deals in the range of 50 - 100 millions dollars. Speaking about the real fund results, this Corporate Investor is 5 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2016. Despite it in 2019 the fund had an activity.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight NantHealth, ARMO BioSciences, Flexus Biosciences. We can highlight the next thriving fund investment areas, such as Biotechnology, Medical Device. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low.

This organization was formed by Robert Hariri, Sol Barer. We also calculated 1 valuable employee in our database.

Notable deals

Review

• No reviews are submitted yet.